- Home
- VECO vs NVAX Comparison
VECO vs NVAX Comparison
Compare VECO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VECO
- NVAX
- Stock Information
- Founded
- VECO 1945
- NVAX 1987
- Country
- VECO United States
- NVAX United States
- Employees
- VECO N/A
- NVAX N/A
- Industry
- VECO Industrial Machinery/Components
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VECO Technology
- NVAX Health Care
- Exchange
- VECO Nasdaq
- NVAX Nasdaq
- Market Cap
- VECO 1.9B
- NVAX 2.0B
- IPO Year
- VECO 1994
- NVAX 1995
- Fundamental
- Price
- VECO $27.00
- NVAX $8.57
- Analyst Decision
- VECO Buy
- NVAX Buy
- Analyst Count
- VECO 7
- NVAX 6
- Target Price
- VECO $42.14
- NVAX $17.83
- AVG Volume (30 Days)
- VECO 543.3K
- NVAX 3.3M
- Earning Date
- VECO 02-12-2025
- NVAX 02-26-2025
- Dividend Yield
- VECO N/A
- NVAX N/A
- EPS Growth
- VECO N/A
- NVAX N/A
- EPS
- VECO 1.35
- NVAX N/A
- Revenue
- VECO $709,094,000.00
- NVAX $885,193,000.00
- Revenue This Year
- VECO $8.83
- NVAX N/A
- Revenue Next Year
- VECO $2.69
- NVAX N/A
- P/E Ratio
- VECO $19.93
- NVAX N/A
- Revenue Growth
- VECO 9.71
- NVAX N/A
- 52 Week Low
- VECO $25.52
- NVAX $3.53
- 52 Week High
- VECO $49.25
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- VECO 42.66
- NVAX 48.28
- Support Level
- VECO $26.62
- NVAX $7.62
- Resistance Level
- VECO $28.09
- NVAX $8.67
- Average True Range (ATR)
- VECO 0.93
- NVAX 0.46
- MACD
- VECO -0.05
- NVAX -0.03
- Stochastic Oscillator
- VECO 10.27
- NVAX 44.60
About VECO Veeco Instruments Inc.
Veeco Instruments Inc is a United States-based company that is principally engaged in designing, developing, and manufacturing thin-film process equipment, which is mainly used to produce electronic devices. The company's product categories by market consist of lighting, display, and power electronics; advanced packaging; MEMS and RF; scientific and industrial; and data storage. The lighting, display, and power electronics market accounts for over half of the total revenue. The company offers products and services in the United States; China; Europe, the Middle East, and Africa, or EMEA; and the rest of the world, with overseas markets contributing the majority of total revenue.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.